BioInsights - Scalable solutions for cell isolation and expansion

Scalable solutions for cell isolation and expansion

Cell & Gene Therapy Insights 2022; 8(7), 687

DOI: 10.18609/cgti.2022.104

Published: 19 July 2022
Evan Zynda


To realize the potential of revolutionary cell therapy treatments, challenges of safety and cost must be addressed. Scale-up of cell manufacture is a key approach to mitigating these issues. CTS™ DynaCellect™ for the isolation and debeading of cells and stirred tank bioreactors for cell culture are two scalable building blocks for cell therapy manufacturing processes that can help combat common industry challenges.